Vietnam Tackles Women's Cancers with New Global-Local Guidelines

HANOI, Vietnam – February 02, 2026 – A landmark international collaboration is set to enhance cancer care for tens of thousands of women across Vietnam. The U.S.-based National Comprehensive Cancer Network (NCCN) and the Vietnam National Cancer Hospital (K Hospital) today announced the publication of new, locally adapted clinical guidelines for treating breast and ovarian cancer, the nation's most pressing women's health malignancies.

This initiative marks a major milestone in a multi-year partnership aimed at harmonizing Vietnam's cancer treatment protocols with global, evidence-based standards, providing a crucial framework to improve patient outcomes and strengthen the nation's healthcare infrastructure.

A Response to a Growing Health Crisis

The new guidelines arrive at a critical time for Vietnam, a nation grappling with a significant and rising cancer burden. Breast cancer stands as the most common malignancy among Vietnamese women, representing about one in every seven new cancer diagnoses. The challenge is compounded by demographics; while globally about one-third of women with breast cancer are under 50, in Southeast Asia, that figure jumps to nearly half, striking women in the prime of their lives and at the heart of their families and careers.

Furthermore, a pervasive issue across Vietnam's healthcare system is late-stage diagnosis. Studies indicate that between 50% and 80% of cancer patients are diagnosed only at stages 3 or 4, when treatment options are more limited and prognoses are significantly poorer. This reality, coupled with a high cancer mortality rate and substantial out-of-pocket costs for patients, creates an urgent need for standardized, effective, and accessible care protocols.

The collaboration directly targets these challenges by providing a clear, evidence-based roadmap for clinicians. "We continuously strive to access, update, and apply the most advanced medical progress worldwide to provide optimal diagnostic and treatment quality for cancer patients in Vietnam," said Prof. Le Van Quang, MD, PhD, Director of K Hospital. "The collaboration with NCCN carries profound significance. NCCN Guidelines embody internationally-recognized standards grounded in the most up-to-date scientific evidence."

Beyond Translation: Tailoring Global Standards for Local Realities

Crucially, the new resources are not simple translations of American guidelines. They are NCCN Guidelines Adaptations, meticulously customized through a collaborative process involving a panel of Vietnamese oncology experts. This ensures the recommendations account for regional practice patterns, the availability of specific technologies and medications, and the unique biological factors of the local patient population.

This deep localization process yields highly practical and relevant clinical tools. A standout example from the new ovarian cancer guidelines is a unique, detailed algorithm for managing the disease during pregnancy. This complex clinical scenario requires a delicate balance to protect both mother and fetus, and the adapted guideline provides explicit criteria for surgical management, chemotherapy timing, and coordinated maternal-fetal monitoring.

"Although uncommon, ovarian cancer during pregnancy requires complex decision-making with a high potential for adverse maternal and fetal outcomes if management is not standardized," explained Dr. Quang, who also chaired the ovarian cancer panel. This contribution, originating from the local Vietnamese panel, showcases the two-way nature of the knowledge exchange.

This sentiment was echoed by NCCN's leadership. "The feedback we get from international experts helps us to improve care in the United States as well," said Crystal S. Denlinger, MD, CEO of NCCN. "We are proud to exchange knowledge that drives research, training, and education for cancer care worldwide."

A Blueprint for National Cancer Control

This latest publication builds upon a foundation of success. The partnership between NCCN and K Hospital was formalized in 2023, leading to the successful adaptation of guidelines for lung and liver cancer. With the addition of breast and ovarian cancer, the collaboration now addresses four major cancers in Vietnam, with plans to expand to colorectal, stomach, and other cancers soon.

As Vietnam's premier oncology institution, K Hospital is uniquely positioned to champion the dissemination and implementation of these guidelines. With a capacity of 2,400 beds across three campuses and a mandate to direct a nationwide network of oncology units, the hospital is the central nervous system for cancer care in the country.

While the guidelines provide a powerful clinical tool, significant hurdles remain. Implementing them effectively will require overcoming systemic challenges, including the high rate of late diagnosis, resource limitations in rural areas, and the financial toxicity of cancer care for many families. However, by establishing a gold standard for treatment, the adapted guidelines create a clear target for investment, training, and policy development.

Dr. Denlinger noted that such resources are foundational for broader health system improvements. "These regionally-adapted guidelines can serve as the basis for a National Cancer Control Plan (NCCP) and provide a foundation for future work to improve cancer treatment and build capacity in Vietnam and globally," she stated. The joint effort to develop and localize these guidelines is seen as a vital step toward harmonizing Vietnam's cancer care with international best practices, ultimately offering new hope and better outcomes for patients. These adapted guidelines represent a critical tool in that ongoing fight, offering a standardized, evidence-based path forward to improve and save the lives of women across Vietnam.